Rheumnow Podcast
1,006 episodes — Page 7 of 21

Ep 1185Top 3 Messages About JAK Inhibitor Safety
Dr. Janet Pope discusses a debate she participated in at Eular 2024 in Vienna, Austria, and her top three messages regarding JAKi safety.

Ep 1184Pain in RA: Different Drugs for Different Mechanisms
Dr. Aurelie Najm reports from Eular 2024 in Vienna, Austria, about abstracts OP0072 and OP0086.

Ep 1183JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Ep 1182Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Dr. Bella Mehta interviews Dr. Vincenzo Venerito about abstract POS0236 at Eular 2024 in Vienna, Austria.

Ep 1181Treat to Target Outcomes in Early AxSpA
Dr. Antoni Chan discusses abstract OP0132 presented at Eular 2024 in Vienna, Austria.

Ep 1180Does Telemonitoring in SpA Work?
Dr. Antoni Chan reports on abstract OP0120 from Eular 2024 in Vienna, Austria.

Ep 1179PsA Treatment: is Earlier Better?
Dr. Aurelie Najm discusses abstract OP0184, presented at Eular 2024 in Vienna, Austria.

Ep 1178JAK Inhibitors for New Indications
Dr. Janet Pope discusses new indications for JAK inhibitors, reporting from Eular 2024 in Vienna, Austria.

Ep 1177Transition from Psoriasis to PsA: Can we Prevent It?
Dr. Aurelie Najm discusses abstract OP0010 presented at Eular 2024 in Vienna, Austria.

Ep 1176EULAR 2024 Daily Recap - Days 1 & 2
Moderated by Dr. Jack Cush and featuring Dr. Yuz Yusof and Dr. Mrinalini Dey

Ep 1175Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
Dr. David Liew reports on abstracts OP0007 and OP0069 at Eular 2024 in Vienna, Austria.

Ep 1174The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Dr. Mrinalini Dey reports from Eular 2024 in Vienna, Austria about an abstract she will present during the meeting, POS0309.

Ep 1173Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib

Ep 1172Voclosporin and Steroids in Lupus Nephritis
Dr. Jack Cush reports on abstract OP0059 presented at Eular 2024 in Vienna, Austria.

Ep 11713 Big Lupus Themes from EULAR 2024
Dr. Janet Pope discusses three hot topics in lupus at Eular 2024 in Vienna, Austria.

Ep 1170Does B Cell Depletion Matter?
Drs. Yuz Yusof and Ed Vital discuss abstract OP0077 at Eular 2024 in Vienna, Austria.

Ep 1169Do MRI changes at the Spine and SI Joints in Treatment of AxSpA Matter?
Dr. Eric Ruderman discusses abstracts OP0046 and POS0058 presented at Eular 2024 in Vienna, Austria. OP0046 Effect on SI joint structural lesions with ixekizumab POS0058 Effect on SI joint structural lesions with bimekizumab

Ep 1168Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib

Ep 1167Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Dr. Eric Ruderman shares his perspectives on the following abstracts being presented at Eular 2024 in Vienna, Austria: OP0195 Sonelokimab IL 17 A/F nanobody inhibitor LB0005 Izokibep IL17A nanobody inhibitor POS0803 Vunakizumab, another IL17A inhibitor OP0138 TAK-279 phase 2B selective TYK2 inhibitor Zasocitinib
Ep 1166Is Cannabis Safe? (6.7.2024)
Dr. Jack Cush reviews FDA approval, news and journal articles -- Its the week before EULAR 2024 in Vienna!!
Ep 1165ACR’s Run at Goliath (PCPs) (5.31.2024)
Dr. Jack Cush reviews the journal reports and articles from this past week on RheumNow.com. The ACR (and Cush) address their new website designed to educate PCPs and APP's - what do you think?
Ep 1164The Window of Opportunity (5.24.2024)
Dr. Jack Cush reviews the journal reports and news from the past week on RheumNow.com. This week blockbuster drugs, opioids in rheumatology and nontreatment of inflammatory arthritis?
Ep 1163Don't You Know Who I am (5.17.2024)
Dr. Jack Cush reviews the news and journal reports from the past 2 weeks. This weeks question - Can we prevent gout, ILD or psoriasis?
Ep 1162My Cancelled Lecture (5.11.2024)
In lieu of this weeks podcast, Dr. Jack Cush records his "Life Lessons (that keep changing) in Rheumatology Lecture. A lecture recently cancelled because some of this content was objectionable? (I dont think so!)

Ep 1161Roadblocks to reaching remission in lupus Sponsored by GSK US Medical Affairs
The 2023 EULAR recommendations for the management of lupus advocate for a treat-to-target approach, aiming for remission or low-level disease activity state.3 In this video, Dr. Michelle Petri summarizes the clinical criteria to attain these targets, and their association with reducing organ damage accrual.
Ep 1160Featured BSR Abstracts (5.3.2024)
Dr. Jack Cush muses on the news, journal reports, FDA announcements and the 2024 BSR abstracts just released.

Ep 1159SLE Faculty Panel Q&A - Featuring Drs. David Karp, Michelle Kahlenberg, and Andrea Fava; moderated by Dr. Jack Cush

Ep 1158Tuesday Night Rheumatology- Mastering SLE
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Rethinking Pre-Clinical Disease in Lupus David Karp, MD Biology and Rx of Lupus Flares Michelle Kahlenberg, MD Current/Future Biomarkers in SLE Andrea Fava, MD

Ep 1157Current & Future Biomarkers in SLE - Dr. Andrea Fava
Ep 1156Rheum Chapter Notes (4.26.2024)

Ep 1155Spondyloarthritis Faculty Panel Q&A - featuring Drs. Eric Ruderman, Lihi Eder, and Lianne Gensler; moderated by Dr. Artie Kavanaugh

Ep 1154Tuesday Night Rheumatology- Spondyloarthritis Spectrum
Join us for session highlights from RheumNow Live 2023. This webinar will feature highlights from these lectures followed by live audience Q & A: Nonradiographic Axial Spondyloarthritis Eric Ruderman, MD Enthesitis in Spondyloarthritis Lihi Eder, MD Future Therapy of Axial Spondyloarthritis Lianne Gensler, MD

Ep 1153Nonradiographic Axial Spondyloarthritis - Dr. Eric Ruderman
Ep 1152Canary in a Coal Mine (4.19.2024)
Dr. Jack Cush reviews regulatory reports, news and novel journal articles - this week focusing on Sjogrens, ILD, Gout and Uveitis.

Ep 1151Vasculitis Faculty Panel Q&A - featuring Drs. Catherine Sims, Anisha Dua, and Philip Seo- moderated by Dr. Jack Cush

Ep 1150Tuesday Night Rheumatology- Vasculitis Mavens
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Vasculitis & Pregnancy Catherine Sims, MD GPA Management in 2024 Anisha Dua, MD, MPH Treat to Target in Vasculitis Philip Seo, MD

Ep 1149GPA Management in 2024 - Dr. Anisha Dua
Ep 1148Burnout or Retire (4.12.2024)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Is it time to worry about burnout and those who are leaving healthcare?

Ep 1147PsA Faculty Panel Q&A - featuring Drs. Alexis Ogdie, April Armstrong, and Lihi Eder; moderated by Dr. Artie Kavanaugh

Ep 1146Choosing Systemic Therapies for Psoriatic Disease - Dr. April Armstrong

Ep 1145RA Faculty Panel - featuring Drs. Brittany Weber, Monica Guma, and Hani El Gabalawy; moderated by Dr. Jack Cush

Ep 1144Prevention of RA - Dr. Hani El Gabalawy

Ep 1143Tuesday Night Rheumatology- Psoriatic Arthritis - Hot Topics
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: EULAR vs ACR vs GRAPPA Guidelines Alexis Ogdie, MD Choosing Systemic Therapies for Psoriatic Disease April Armstrong, MD Gender Differences in PsA Outcomes & Management Lihi Eder, MD
Ep 11421 in 600 Falls May Die (4.5.2024)
Dr. Jack Cush reviews the news and Journal reports from this past week on RheumNow.com - including problems w/ falls, pain and treatment of Dupuytrens contractures.

Ep 1141Tuesday Night Rheumatology- Success in Rheumatoid Arthritis
Join us for session highlights from RheumNow Live 2024. This webinar will feature highlights from these lectures followed by live audience Q & A: Lessons from Cardio-Rheumatology Clinic RA Brittany Weber, MD Nutrition in RA Monica Guma, MD Prevention of RA Hani El Gabalawy, MD
Ep 1140Activity & Pain Tolerance (3.29.2024)
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com, including on where you should sit in clinic and why you should worry about secondary Sjogrens in RA.
Ep 1139Naysayers & Disrupters (3.22.2024)
Dr. Jack Cush reviews the news and journal reports from the past week - including a few contrary reports on infection, seropositivity and plasmapheresis.
Ep 1138Ides of March (3.15.2024)
Dr. Jack Cush has advise for Cesar and the superstitious and covers pregnancy, platelets, dialysis and vaccinations in Lupus.
Ep 1137Depression and RA (3.8.2024)
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from the past week.

Ep 1136Perspectives on the 2023 EULAR Recommendations for Systemic Lupus Erythematosus
Hear Dr. Richard Furie and Dr. Leanna Wise discuss clinical considerations related to the 2023 EULAR treatment recommendations for SLE. US-85292 last updated 2/24.